MDGL Faces Multi‑Firm Securities Investigation After 8% Stock Drop
SEC and law firm investigations hit Madrigal Pharmaceuticals over alleged securities fraud, prompting investors to seek counsel amid sharp stock falls.
- MADRIGAL PHARMACEUTICALS INC
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
3 minutes to read